Search

Author/Creator Combier, Alice

1. AB0462 IMMUNIZATIONTO RITUXIMAB IS MORE FREQUENT IN AUTOIMMUNE SYSTEMIC AUTOIMMUNE DISEASES THAN IN RHEUMATOID ARTHRITIS AND MAY BE MANAGED BY SWITCHING FROM RITUXIMAB TO OFATUMUMAB. (June 2019)

Authors:
Combier, Alice; Nocturne, Gaetane; Henry, Julien; Belkhir, Rakiba; Pavy, Stephane; Mariette, Xavier; Seror, Raphaèle
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy. (9th October 2019)

Authors:
Combier, Alice; Nocturne, Gaétane; Henry, Julien; Belkhir, Rakiba; Pavy, Stephan; Le Tiec, Clotilde; Descamps, Elise; Seror, Raphaele; Mariette, Xavier
Journal:
Rheumatology
Issue:
Volume 59:Number 6(2020)
Page Start:
1347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection. Issue Volume 61:Issue S12(2020) (31st March 2022)

Authors:
Avouac, Jérôme; Ghossan, Roba; Al Tabaa, Omar; Combier, Alice; Steelandt, Alexia; Thomas, Marion; Fogel, Olivier; Mariaggi, Alice Andrée; Meritet, Jean-François; Rozenberg, Flore; Molto, Anna; Miceli-Richard, Corinne; Allanore, Yannick
Journal:
Rheumatology
Issue:
Volume 61:Issue S12(2020)
Page Start:
SI191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients. Issue Volume 61:Issue S12(2020) (2nd November 2021)

Authors:
Avouac, Jérôme; Miceli-Richard, Corinne; Combier, Alice; Steelandt, Alexia; Fogel, Olivier; Mariaggi, Alice Andrée; Meritet, Jean-François; Rozenberg, Flore; Molto, Anna; Allanore, Yannick
Journal:
Rheumatology
Issue:
Volume 61:Issue S12(2020)
Page Start:
SI163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Issue 1 (January 2023)

Authors:
Guillo, Lucas; Flachaire, Benoit; Avouac, Jérôme; Dong, Catherine; Nachury, Maria; Bouguen, Guillaume; Buisson, Anthony; Caillo, Ludovic; Fumery, Mathurin; Gilletta, Cyrielle; Hébuterne, Xavier; Lafforgue, Pierre; Laharie, David; Mahé, Emmanuel; Marotte, Hubert; Nancey, Stéphane; Ottaviani, Sébas...
Journal:
Digestive and liver disease
Issue:
Volume 55:Issue 1(2023)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗